Journal Retracts Peer-Reviewed Study Linking COVID Vaccines to Cancer After Reuters ‘Fact Checks’ It

by Brenda Baletti, Ph.D., Childrens Health Defense:

Mortality for some cancers increased by as much as 9.7%, according to a study by Japanese researchers who analyzed government statistics to compare age-adjusted cancer mortality rates during the COVID-19 pandemic (2020-2022) with pre-pandemic rates.

The journal Cureus last week retracted a Japanese study that found statistically significant increases in cancer mortality following COVID-19 vaccination, especially after the third COVID-19 shot.


The journal said on its website, “Upon post-publication review, it has been determined that the correlation between mortality rates and vaccination status cannot be proven with the data presented in this article.” This invalidated the results, prompting the retraction, the journal said.

Denis Rancourt, Ph.D., all-cause mortality researcher and former physics professor at the University of Ottawa in Canada, who also has published in Cureus, on X, formerly known as Twitter, called the retraction “baseless.”

“Showing data in support of vaccine-induced cancer is not allowed: burn it,” he wrote.

Other scientists also expressed frustration with the retraction.

“Unfortunately, one more scientific study that challenges the established narrative gets retracted,” Panagis Polykretis, Ph.D., a researcher at Italy’s Institute of Applied Physics at the National Research Council said in an email shared with The Defender. “One more outrageous and unjustified example of censorship takes place!”

The study, published in April, analyzed official Japanese government statistics to compare age-adjusted cancer mortality rates during the COVID-19 pandemic (2020-2022) with pre-pandemic rates.

The researchers found a 2.1% mortality increase in 2021 and a 9.6% increase In 2022.

They determined that age-adjusted death rates for leukemia, breast, pancreatic and lip/oral/pharyngeal cancers increased significantly in 2022 after a large portion of the Japanese population had received the third dose of an mRNA COVID-19 vaccine.

Overall, they found no significant cancer-related excess mortality in 2020, but a 1.1% increase in 2021 after the rollout of the first and second vaccine doses, and a 2.1% increase in 2022.

Read More @

Originally Posted at